Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 175, Issue 5, Pages 2121-2132Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2009.090418
Keywords
-
Categories
Funding
- Global Centers of Excellence program
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
- Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation
- Hori Information Science Promotion Foundation
- Ministry of Health, Labor and Welfare of Japan [H20-007]
Ask authors/readers for more resources
Soluble oligomeric amyloid beta (oA beta) 1-42 causes synaptic dysfunction and neuronal injury in Alzheimer's disease (AD). Although accumulation of microglia around senile plaques is a hallmark of AD pathology, the role of microglia in oA beta 1-42 neurotoxicity is not fully understood. Here, we showed that oA beta but not fibrillar A beta was neurotoxic, and microglia activated with unmethylated DNA CpG motif (CpG), a ligand for Toll-like receptor 9, attenuated oA beta 1-42 neurotoxicity in primary neuron-microglia co-cultures. CpG enhanced microglial clearance of oA beta 1-42 and induced higher levels of the antioxidant enzyme heme oxygenase-1 in microglia without producing neurotoxic molecules such as nitric oxide and glutamate. Among subclasses of CpGs, class B and class C activated microglia to promote neuroprotection. Moreover, intracerebroventricular administration of CpG ameliorated both the cognitive impairments induced by oA beta 1-42 and the impairment of associative learning in Tg2576 mouse model of AD. We propose that CpG may he an effective therapeutic strategy for limiting oA beta 1-42 neurotoxicity in AD. (Am J Pathol 2009, 175:2121-2132; DOI: 10.2353/ajpath.2009.090418)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available